Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00436228 · ClinicalTrials.gov registry record
To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 32
- Enrollment target
NCT00436228 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 32 participants.
The verdict
NCT00436228 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
SB-742510 is a semi-synthetic pleuromutilin antibiotic that is being developed for treatment of respiratory infections. The purpose of this study is to estimate the bioavailability of four different formulations and to evaluate the safety of each of the four formulations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00436228
The ClinicalTrials.gov registry entry for NCT00436228 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00436228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00436228 about?
NCT00436228 is a clinical study titled "To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug". SB-742510 is a semi-synthetic pleuromutilin antibiotic that is being developed for treatment of respiratory infections. The purpose of this study is to estimate the bioavailability of four different formulations and to evaluate the safety of each of the four formulations
What is the current status of trial NCT00436228?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2006-11. Estimated completion is 2007-02.
Who is sponsoring clinical trial NCT00436228?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.